|
Volumn 53, Issue 10, 1993, Pages 811-819
|
16β-[18F]fluoromoxestrol: A potent, metabolically stable positron emission tomography imaging agent for estrogen receptor positive human breast tumors
a,b,c a a b b a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DIAGNOSTIC AGENT;
DRUG DERIVATIVE;
ESTROGEN RECEPTOR;
ETHINYLESTRADIOL;
FLUORINE;
FLUOROMOXESTROL;
16ALPHA FLUOROESTRADIOL;
16BETA FLUOROMOXESTROL;
ESTROGEN;
FLUORINE 18;
UNCLASSIFIED DRUG;
ANIMAL;
ARTICLE;
BREAST TUMOR;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
CYTOLOGY;
FEMALE;
HUMAN;
LIVER;
METABOLISM;
RAT;
RAT STRAIN;
SCINTISCANNING;
ULTRASTRUCTURE;
ANIMAL CELL;
ANIMAL TISSUE;
BABOON;
CONTROLLED STUDY;
DOSIMETRY;
DRUG DISTRIBUTION;
DRUG METABOLISM;
DRUG PROTEIN BINDING;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY;
LIVER CELL;
MUSCLE;
NONHUMAN;
OVARY;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
THYMUS;
UTERUS;
ANIMAL;
BREAST NEOPLASMS;
ETHINYL ESTRADIOL;
FEMALE;
FLUORINE RADIOISOTOPES;
HUMAN;
LIVER;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, ESTROGEN;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, NON-P.H.S.;
SUPPORT, U.S. GOV'T, P.H.S.;
TOMOGRAPHY, EMISSION-COMPUTED;
|
EID: 0027337360
PISSN: 00243205
EISSN: None
Source Type: Journal
DOI: 10.1016/0024-3205(93)90503-U Document Type: Article |
Times cited : (37)
|
References (38)
|